Northside Hospital, Inc.

This study looks at whether CAR T cell therapy can be safely given to people with blood cancers who also have moderate to severe kidney problems. Researchers will adjust the standard chemotherapy given before the CAR T cells to protect the kidneys. The goal is to see how often si…

This study tests a bone marrow transplant from a half-matched (haploidentical) donor for people with severe aplastic anemia, a rare condition where the bone marrow fails to make enough blood cells. The goal is to see if this approach can safely restore normal blood cell productio…

This study tests whether a drug called sargramostim can help the body rebuild its infection-fighting cells faster after a special type of stem cell transplant for blood cancers. About 38 adults with cancers like leukemia or lymphoma will receive the drug after a half-matched dono…

This study tests whether giving the immune-suppressing drug tacrolimus earlier than usual can lower the risk of cytokine release syndrome (CRS), a severe inflammatory reaction, after a half-matched stem cell transplant. About 20 adults with blood cancers who are getting their fir…

This study tests whether giving chemotherapy into the spinal fluid before and during blinatumomab treatment can prevent nerve-related side effects in adults with acute lymphoblastic leukemia. About 20 participants will receive the adjusted schedule. The goal is to keep the leukem…